![](https://www.dimabio.cn/wp-content/uploads/pages/7f794d61becaf5f3af31e6f0290dd96313ccd2f9.jpg)
缔码生物2023企宣视频
公司计划在未来的3-5年完成所有可成药靶点的先导抗体分子制备并且针对每个靶点提供多个预制的先导抗体分子,拥有创新型功能膜蛋白开发、单B细胞先导抗体发现、抗体工程改造与功能验证平台,旨在让药企跨过单抗平台建立和先导分子筛选的门槛,加速推进临床管线。
![](https://www.dimabio.cn/wp-content/uploads/pages/dac13602208edef99172587f487605ae1152c2e9.jpg)
如何应用全药靶预制先导抗体分子快速推进临床
![](https://www.dimabio.cn/wp-content/uploads/pages/19a039c9a660b401de1a1f9d0e16ab080e46820a.jpg)
【缔码生物】重组兔单抗在CAR-T细胞治疗载体开发中的应用
![](https://www.dimabio.cn/wp-content/uploads/pages/b512a8a147f031c20e1ec0510eb7ba87767ff2c2.jpg)
缔码nanodisc平台介绍,高效制备全长多跨膜蛋白
![](https://www.dimabio.cn/wp-content/uploads/pages/a5bc768dc12e9a0c73f6ca54bd88742b526b22e0.jpg)
缔码生物CAR-T先导分子临床前研发技术与解决方案
![](https://www.dimabio.cn/wp-content/uploads/pages/c4c094846de1dd4512117fdaeaeb3f804787732b.jpg)
缔码药靶先导抗体分子发现和解决方案
![](https://www.dimabio.cn/wp-content/uploads/pages/9b82dd43d525be094f3efd8c702e2e19d7d5d880.jpg)
在创业创新成本愈来愈高的情况下,企业应该如何发展?
![](https://www.dimabio.cn/wp-content/uploads/pages/c248cef0ac0d80c50803f005b728ee37479b9f36.jpg)
抗体深度人源化服务,可提高抗体亲和力,降低免疫原性,助力抗体药物开发
![](https://www.dimabio.cn/wp-content/uploads/pages/71f6f686c1c24b0837db9104ed327fbdd49cfd33.jpg)
缔码药靶先导抗体分子发现和解决方案——Therapeutic lead antibody discovery and solutions
![](https://www.dimabio.cn/wp-content/uploads/pages/dac13602208edef99172587f487605ae1152c2e9.jpg)
Using Single B Technology to Develop Lead Antibody Molecules on GPCR Targets
![](https://www.dimabio.cn/wp-content/uploads/pages/42e03708b42d667e524a0b89eeb2d6ceb12c6873.png)
DiLibrary™基于哺乳动物细胞展示技术的抗体工程